Showing 4091-4100 of 10627 results for "".
Identifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
https://reachmd.com/programs/clinicians-roundtable/identifying-hidden-risk-metabolomic-patterns-in-childhood-obesity/39654/Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
https://reachmd.com/programs/project-oncology/evaluating-digital-cbt-for-sickle-cell-disease-insights-from-the-carisma-trial/36526/CRISPR in Sickle Cell: Transforming Care Through Gene Editing
https://reachmd.com/programs/project-oncology/crispr-in-sickle-cell-transforming-care-through-gene-editing/36233/CRISPR technology, while relatively new, has shown potential in treating patients with sickle cell disease by increasing fetal hemoglobin. Though this gene therapy comes with safety considerations, refinements and advancements in CRISPR technology can offer new management options for sickle cell disClinical Insights Into T-Cell Immunity After Pediatric COVID-19 mRNA Vaccination
https://reachmd.com/programs/clinicians-roundtable/clinical-insights-into-t-cell-immunity-after-pediatric-covid-19-mrna-vaccination/37133/Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
https://reachmd.com/programs/heart-matters/Integrating-Lipoprotein-a-Into-Cardiovascular-Risk-Assessment/37595/Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
https://reachmd.com/programs/project-oncology/subcutaneous-isatuximab-matches-iv-in-multiple-myeloma-insights-from-iraklia/36403/The phase 3 IRAKLIA trial evaluated the subcutaneous delivery of isatuximab via an on-body injector plus pomalidomide and dexamethasone versus the standard IV regimen in patients with relapsed/refractory multiple myeloma. Results showed comparable overall response rates, steady-state trough concentrEarly CRC Screening: Uptake Strong in Younger Adults Using Stool DNA Test
https://reachmd.com/programs/clinicians-roundtable/early-crc-screening-uptake-strong-in-younger-adults-using-stool-dna-test/36405/Practice Growth Considerations in Challenging Times
https://reachmd.com/ma-issues-index/2022-nov-dec/practice-growth-considerations-in-challenging-times-2/35232/Processes to ensure smart business decisions for growth.Eye Trends
https://reachmd.com/ma-issues-index/2022-nov-dec/eye-trends/35228/Highlights of new and unique treatments for the eyelid area.Embracing the Diversifying Aesthetics Market
https://reachmd.com/ma-issues-index/2022-nov-dec/embracing-the-diversifying-aesthetics-market/35225/The aesthetics market is diversifying in terms of age, gender identity, and race and ethnicity.